PT  - JOURNAL ARTICLE
AU  - Tyler A. Dailey
AU  - Michael D. Berven
AU  - Penny J. Vroman
TI  - <sup>99m</sup>Tc-HMPAO–Labeled WBC Scan for the Diagnosis of Chronic Recurrent Multifocal Osteomyelitis
AID  - 10.2967/jnmt.114.138073
DP  - 2014 Dec 01
TA  - Journal of Nuclear Medicine Technology
PG  - 299--301
VI  - 42
IP  - 4
4099  - http://tech.snmjournals.org/content/42/4/299.short
4100  - http://tech.snmjournals.org/content/42/4/299.full
SO  - J. Nucl. Med. Technol.2014 Dec 01; 42
AB  - The goal of this teaching case study is to demonstrate the novel use of 99mTc-HMPAO-labeled white blood cells (WBCs) in diagnosing chronic recurrent multifocal osteomyelitis (CRMO). 99mTc-HMPAO-labeled white blood cells were utilized to diagnose CRMO. Classically, CRMO is evaluated scintigraphically using 99mTc-methylene diphosphonate/hydroxymethylene diphosphonate. 99mTc-HMPAO-labeled WBCs were chosen over 111In-labeled WBCs because of the former's improved imaging characteristics and decreased radiation dose. 99mTc-HMPAO-labeled WBCs were successful in diagnosing CRMO. 99mTc-HMPAO-labeled WBC scanning is specific for the diagnosis of CRMO.